The role of serology in active ocular toxoplasmosis by Papadia, Marina et al.
ORIGINAL PAPER
The role of serology in active ocular toxoplasmosis
Marina Papadia • Raffaella Aldigeri •
Carl P. Herbort
Received: 24 August 2011 / Accepted: 22 December 2011 / Published online: 11 January 2012
 Springer Science+Business Media B.V. 2012
Abstract Our purpose was to examine toxoplasmic
serology in relation to episodes of suspected acute
toxoplasmic retinochoroiditis and evaluate its use in
the appraisal of patients. The mean values of enzy-
matic immunoassay (EIA) titers for toxoplasmic
antibodies were retrospectively compared in patients
with active and inactive toxoplasmosis and in a third
group of uveitis cases not caused by toxoplasmosis.
The proportion of cases under and above a predefined
serology value above cut-off was compared in all
groups. Between 1995 and 2010, 97 out of 1,276 new
uveitis cases seen at the Centre for Ophthalmic
Specialized Care (COS), Lausanne, Switzerland were
diagnosed as toxoplasmic retinochoroiditis, of which
51 had documented serology available. The mean EIA
values for immunoglobulin (Ig) G were 147.75 ±
259.4 IU/ml for patients with active disease, 18.93 ±
23.09 (p \ 0.05) for patients with inactive toxoplas-
mosis and 18.35 ± 20.82 for controls (p \ 0.017).
The proportion of cases under the designated limit
value were 2/51 (4%) in the active retinitinochoroiditis
group, 14/27 (52%) (p \ 0.05) in the control group,
and 7/7 (100%) in the inactive toxoplasmic group
(p \ 0.001). Three out of 51 cases showed high IgM
values in addition to IgG elevation and were primary
infections. Toxoplasmosis serology, contrary to pop-
ular belief, is useful to confirm active toxoplasmic
retinochoroiditis; it is easy to perform, cheap and
supports clinical diagnosis in up to 96% of cases, not
only by showing positivity but by also showing a
significant elevation of titers. In atypical cases serol-
ogy is not only useful but essential.
Keywords Serology  Toxoplasmic
retinochoroiditis  Active disease  Atypical cases
Introduction
The usefulness of toxoplasmosis serology is very often
downplayed in textbooks and articles on the topic, and
at uveitis symposia, being mostly regarded as unnec-
essary [1]. In most cases toxoplasmic retinochoroiditis
is a recurrence of a previous systemic infection and
only positive for immunoglobulin (Ig) G [2]. Serology
is nevertheless essential to establish previous infection
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in order to be able to attribute the disease to this agent,
even though it is said that the diagnosis is mainly
clinical [3]. It has often been noted that the increase in
IgG anti-toxoplasmic titers is associated with recur-
rent disease [4]. This shows that in toxoplasmic reti-
nochoroiditis, even when it presents as the first apparent
ocular episode, a silent systemic primo-infection has
occurred previously with the clandestine establishment
of cysts in the retina [5]. It has to be emphasized,
contrary to all publications published before the 1990s,
that absence of IgM does not indicate that we are dealing
with a congenital disease, but that most cases of
toxoplasmic retinochoroiditis are due to acquired toxo-
plasmosis following a previous undetected primary
infection [6, 7].
In this study we wanted to explore toxoplasmic
serologies in episodes of acute toxoplasmic retinoch-
oroiditis, in patients with an inactive toxoplasmic scar
and in a control group of uveitis patients.
Materials and methods
We retrospectively reviewed 1,276 charts of uveitis
patients that presented to the Centre for Ophthal-
mic Specialized Care (COS), Lausanne, Switzerland
between 1995 and 2010.
All research followed the tenets of the declaration
of Helsinki.
The aim of the study was to analyze serological data
of patients with active retinochoroiditis and compare
them to a group of patients with inactive ocular toxo-
plasmosis and a group of controls. The control group
consisted of other uveitis patients in whom toxoplas-
mic serology had been performed as part of a general
work-up and found to be positive, but where toxo-
plasmic etiology of the ocular disease could be ruled
out on the basis of the clinical appearance of the
disease.
For this purpose, the mean IgG titers of enzymatic
immunoassay (EIA) for toxoplasmic antibodies were
compared in the three groups and, furthermore, the
proportion of cases under and above a value of serology
fixed at four times or at twenty times the cut-off value
was compared in the active and inactive toxoplasmosis
groups and in the control group.
EIA was performed to obtain toxoplasmic serology.
EIA is a biochemical technique used mainly in
immunology to detect the presence of an antibody or
an antigen in a sample. In this setting it was used to
detect and quantify an unknown amount of anti-
toxoplasmic antibodies taken from the serum of a
patient. In brief, serum from a patient with an unknown
amount of a specific antibody is poured into a recipient
coated with the corresponding antigen. The antibody
will bind to the antigen and create a complex. An
antibody to IgG linked to an enzyme is then washed
over the surface so that it can bind to the complex. In
the final step a substance is added to enable the fixed
enzyme to convert to a detectable signal. Thus, when a
light of the appropriate wavelength is shone upon the
sample, the antigen/antibody complexes will fluoresce
so that the amount of antibody in the sample can be
inferred through the magnitude of the fluorescence.
Data entry and statistical analysis were performed
using SPSS version 17.0 software. ANOVA was used
to compare the mean values of toxoplasmosis anti-
bodies among groups. Differences in proportions of
high levels of antibodies were evaluated by Pearson’s
Chi-squared test. A statistical test result was consid-
ered significant with a p value of\0.05.
Results
Ninety-seven out of 1,276 new uveitis patients seen at
Centre for Ophthalmic Specialized Care (COS),
Lausanne, Switzerland between 1995 and 2010 were
found to be affected by toxoplasmosis retinochoroid-
itis on the basis of clinical signs.
The demographic data of the three groups are
shown in Table 1.
Eighty-five cases had active disease and 51 had
documented serology for Toxoplasma gondii. All
these patients had either a retinochoroidal focus
(n = 49) or a papillitis (n = 2). In one third of
patients (n = 16, 31%) a focus without a juxtalesional
scar was found, indicating that the proportion of cases
with a so-called ‘typical’ presentation was no more
than two-thirds. Table 2 summarizes the results of
serology in the three groups.
The mean EIA values were 147.75 ± 259.4 inter-
national units (IU/ml) in patients with active reti-
nochoroiditis (n = 51), 18.35 ± 20.82 IU/ml in
controls (n = 27) (p \ 0.05), and 18.93 ± 23.09 IU/
ml in patients with inactive toxoplasmosis (n = 7)
(p \ 0.017) (Fig. 1). A post hoc analysis confirmed a
significant difference in the mean EIA values between
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patients with active retinochoroiditis and the control
group (Bonferroni method, p \ 0.05).
Forty-nine patients (96%) had titers above the
chosen limit considered as an elevated titer (Table 2).
Three patients also presented a high IgM titer
indicating a primary ocular infection. In the inactive
toxoplasmosis group 0/7 patients (false positives)
had elevated titers and in the control group 13/27
(48%) patients (false positives) had elevated titers
(Table 2).
The high number of false positives in the control
group of uveitis patients is most probably explained by
the fact that the proportion of cases of sarcoidosis in
this group was high. It is well known that sarcoidosis
patients present a rise of antibodies against latent
infections [8].
When the defined serology value was fixed at 20
times cut-off value, 23/51 (45%) patients with active
disease were positive and only 2/27 (7%) controls
were positive, and none was positive in the inactive
cases.
Chi-squared test confirmed a significant association
between high levels of toxoplasmosis antibodies and
the presence of active retinochoroiditis (p \ 0.001).
Based on these data, the EIA test was very sensitive
(49/51 positive tests in the presence of disease,
sensitivity = 96%) and less specific (13/27 negative
tests in the absence of disease, specificity = 48%)
when the defined value was four times the cut-off
value; however, it was more specific (25/27 true
negatives, specificity = 93%) when the defined value
was 20 times the cut-off value.
Figure 1 shows graphically the comparison of
mean EIA titers for toxoplasmic antibodies in patients
with active and inactive toxoplasmosis and in a third
group of uveitis cases (control group) (Fig. 2).
Table 1 Demographic data of the patients
Patients with active
retinochoroiditis (n = 51)
Controls (n = 27) Patients with inactive
retinochoroiditis (n = 7)
Sex ratio (M/F) 22/29 11/16 4/3
Mean age ± SD 36.55 ± 17.54 50.78 ± 17.34 34.67 ± 19.32
Table 2 Data on serological test
Active
disease
(n = 51)
Control
(n = 27)
Inactive
disease
(n = 7)
Serological test (4 times
cut-off value of anti-
toxoplasma IgG titer)
49 13 0
Serological test (20 times
cut-off value of anti-
toxoplasma IgG titer)
23 2 0
Fig. 1 Comparison of
mean EIA titers for
toxoplasmic antibodies in
patients with active and
inactive toxoplasmosis and
in a third group of uveitis
cases (control group)
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Discussion
To date, in the literature and at uveitis conferences the
role of toxoplasmic serology in toxoplasmic retinoch-
oroiditis has been downplayed and even considered
irrelevant. This comes from the fact that general
serology laboratories where samples from ocular
patients are tested, do not understand the exact
purpose of requesting a serology workup in a patient
with ocular toxoplasmosis. They invariably respond
that the serology shows an old toxoplasmic infection
and is negative for an acute infection (no IgM). This is
an adequate response for internal medicine patients
where an acute infection is usually searched for and
motivates the serology quest. However, in ocular
patients where, in the overwhelming majority of cases,
the disease is the result of a recurrence, we need to
know whether a clinical picture compatible with
ocular toxoplasmosis is actually due to T. gondii and
we therefore need to know if the patient has ever been
in contact with the agent; this is confirmed by the
presence of even low levels of IgG. Our study shows
that in active cases of toxoplasmic retinochoroiditis,
serology can be more rewarding. In 96 of 100 patients
with an active uveitis compatible with ocular toxo-
plasmosis, a significant elevation of IgG titers (4 times
the cut-off value) was found, indicating that serology
is very sensitive and reasonably specific when com-
pared to the control group (uveitis cases). If we
consider titers 20 times higher than the cut-off value
(very high titers) the specificity rises to 93%.
When a clinician is dealing with suspected toxo-
plasmic retinochoroiditis, serology will not only be
positive, showing that the patient has at one point been
in contact with the agent, but there is also a 96% chance
of finding an elevated IgG titer, making serology very
sensitive in confirming a suspected diagnosis. More-
over if titers are very high (20 times cut-off value),
serology is not only very sensitive but also very
specific. A positive value in this situation means that
the case can only be ocular toxoplasmosis. Such
laboratory information is not to be neglected in typical
cases but is essential in so-called atypical cases.
In summary, serology is useful in all active cases of
suspected toxoplasmic retinochoroiditis. Very high
titers are specific for toxoplasmic disease, thus con-
firming the suspected diagnosis. This is very impor-
tant, especially in atypical cases.
Fig. 2 Column graph
indicating the
discriminatory power of
serology
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